Effectiveness and Safety of Cefiderocol in Clinical Practice for Treatment of Patients with Gram-Negative Bacterial Infections: US Interim Results of the PROVE Study.
Saved in:
| Title: | Effectiveness and Safety of Cefiderocol in Clinical Practice for Treatment of Patients with Gram-Negative Bacterial Infections: US Interim Results of the PROVE Study. |
|---|---|
| Authors: | Clancy CJ; Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA., Cornely OA; Institute of Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University Hospital Cologne, Faculty of Medicine, University of Cologne, Cologne, Germany.; Department I of Internal Medicine, Excellence Center for Medical Mycology (ECMM), University Hospital Cologne, Faculty of Medicine, University of Cologne, Cologne, Germany.; German Centre for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany., Marcella SW; Global Epidemiology and Real-World Evidence, Shionogi Inc, Florham Park, NJ, USA., Nguyen ST; Medical Affairs, Shionogi Inc, Florham Park, NJ, USA., Gozalo L; Advanced Analytics, Genesis Research, Hoboken, NJ, USA., Cai B; Center of Real-World Data and Analytics, Shionogi Inc, Florham Park, NJ, USA. |
| Source: | Infection and drug resistance [Infect Drug Resist] 2024 Oct 15; Vol. 17, pp. 4427-4443. Date of Electronic Publication: 2024 Oct 15 (Print Publication: 2024). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Dove Medical Press Country of Publication: New Zealand NLM ID: 101550216 Publication Model: eCollection Cited Medium: Print ISSN: 1178-6973 (Print) Linking ISSN: 11786973 NLM ISO Abbreviation: Infect Drug Resist Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
